APA (7th ed.) Citation

Kidawara, Y., Kadoya, M., Kakutani-Hatayama, M., & Koyama, H. A Case in Which HLA-DR4 is Involved in the Development of Complex Immune-Related Endocrinological Adverse Events following Combination Therapy with Nivolumab and Ipilimumab. Wiley.

Chicago Style (17th ed.) Citation

Kidawara, Yonekazu, Manabu Kadoya, Miki Kakutani-Hatayama, and Hidenori Koyama. A Case in Which HLA-DR4 Is Involved in the Development of Complex Immune-Related Endocrinological Adverse Events Following Combination Therapy with Nivolumab and Ipilimumab. Wiley.

MLA (9th ed.) Citation

Kidawara, Yonekazu, et al. A Case in Which HLA-DR4 Is Involved in the Development of Complex Immune-Related Endocrinological Adverse Events Following Combination Therapy with Nivolumab and Ipilimumab. Wiley.